Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for De Novo AML patients

M. Clavio, S. Gatto, G. Beltrami, S. Quintino, L. Canepa, I. Pierri, V. Galbusera, P. Carrara, M. Miglino, R. Varaldo, F. Ballerini, C. Venturino, R. Cerri, M. Risso, E. Balleari, A. M. Carella, M. Sessarego, R. Ghio, A. Bacigalupo, Marco Gobbi

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for De Novo AML patients'. Together they form a unique fingerprint.

Medicine & Life Sciences